Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. (2013)

First Author: Moles A

Attributed to: MICA: Illuminating mechanisms regulating the birth, life and death of the myofibroblast to inform the development of antifibrotics for liver disease. funded by MRC

No abstract provided

PubMed Identifier: 22996371

Type: Journal Article/Review

Volume: 57

Parent Publication: Hepatology (Baltimore, Md.)

Issue: 2

ISSN: 0270-9139